BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 30628957)

  • 1. Biomarkers enhance the long-term predictive ability of the KAMIR risk score in Chinese patients with ST-elevation myocardial infarction.
    Wang JJ; Fan Y; Zhu Y; Zhang JD; Zhang SM; Wan ZF; Su HL; Jiang N
    Chin Med J (Engl); 2019 Jan; 132(1):30-41. PubMed ID: 30628957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine enhances the predictive value of the GRACE risk score in patients with ST-elevation myocardial infarction.
    Fan Y; Wang J; Zhang S; Wan Z; Zhou D; Ding Y; He Q; Xie P
    Anatol J Cardiol; 2017 Sep; 18(3):182-193. PubMed ID: 28782750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    He PC; Duan CY; Liu YH; Wei XB; Lin SG
    BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV6 Is Associated with Prognosis of ST-Elevation Acute Myocardial Infarction.
    Zhang H; Ding P; Zheng L
    Ann Clin Lab Sci; 2020 Nov; 50(6):775-780. PubMed ID: 33334793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
    Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
    J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
    Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
    BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction.
    Lu PJ; Gong XW; Liu Y; Tian FS; Zhang WJ; Liu YW; Yao ZH; Wang JX; Han P; Yang YN; Cui Z; Gao J
    Am J Cardiol; 2021 Feb; 140():13-19. PubMed ID: 33159905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
    Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
    Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
    Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B
    Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
    Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
    Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of the serum level of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in left ventricular remodeling after acute myocardial infarction.
    Xiaozhou H; Jie Z; Li Z; Liyan C
    J Clin Lab Anal; 2006; 20(1):19-22. PubMed ID: 16470530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction.
    Khan SQ; Kelly D; Quinn P; Davies JE; Ng LL
    Heart; 2007 Jul; 93(7):826-31. PubMed ID: 17194712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.